Japan, Sept. 16 -- BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV has got intellectual property rights for 'CONTROLLED HYDROGEL DELIVERY OF FOCAL ADHESION KINASE INHIBITOR FOR DECREASED SCAR FORMATION.' Other related details are as follows:
Application Number: JP,2024-102853
Category (FI): A61P43/00,111,A61L15/42,310,A61L15/44,100,A61K31/506,A61P17/02,A61K9/70,A61K31/4439,A61K31/5377,A61K45/00,A61K47/42,A61K47/36,A61L15/32,310,A61L15/28,100,A61P17/14
Stage: PROBLEM TO BE SOLVED: To provide topical biomaterial-based dressings that allow for targeted and controlled release of pharmacological inhibitors, and compositions of improving healing, particularly for amelioration of scarring.SOLUTION: A composition for promoting tissue healing comprises: a porous scaffold; and focal adhesion kinase (FAK) inhibitor disposed in pores of the scaffold, wherein the composition is configured to deliver a dose of FAK inhibitor effective to promote tissue healing at a controlled rate during a treatment time.SELECTED DRAWING: Figure 1 (Grant)
Filing Date: June 26, 2024
Publication Date: Sept. 10, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
